Duett Vascular Graft System
Vascular anastomosis during open surgical aortic arch reconstruction
Key Facts
About Aquedeon Medical
Aquedeon Medical is a clinical-stage medical device developer focused on improving outcomes in aortic arch reconstruction surgery. The company's lead product, the Duett Vascular Graft System, aims to reduce circulatory arrest time by simplifying the connection of vascular grafts to native vessels, potentially lowering procedural risk and complexity. Having secured FDA Investigational Device Exemption (IDE) approval, the company is actively conducting a clinical trial (NCT06253143) to evaluate the system's safety and effectiveness. Aquedeon operates as a pre-revenue, private entity leveraging a surgeon-centric innovation philosophy to address a significant unmet need in cardiothoracic and vascular surgery.
View full company profile